Skip to content

8-KAccepted Sep 10, 7:53 AM ET

Corteva, Inc. Reaches NC PFAS Settlement — Corteva’s Share ~$66M

CTVACorteva, Inc.

Accepted (ET)

7:53 AM

Sep 10, 2026

Filed

Sep 10, 2026

Documents

23

Size

686.2 KB

Summary

Corteva, Inc. Reaches NC PFAS Settlement — Corteva’s Share ~$66M

Updated

What Happened

  • Corteva, Inc. (and subsidiary EIDP) announced a settlement with the State of North Carolina and multiple counties and municipalities to resolve statewide PFAS claims and Fayetteville Works site–related claims. The parties (Corteva/EIDP, Chemours and DuPont) will collectively pay $455 million to North Carolina and applicable subdivisions over 15 years. Corteva’s direct share of that payment is approximately $66 million.
  • As part of the agreement (settlement dated September 9, 2026), Corteva and DuPont will guarantee Chemours’ settlement obligations on a 29% (Corteva) / 71% (DuPont) basis. The companies must also establish a reserve mechanism (line of credit, letter of credit, and/or surety bond) capped at $135 million that North Carolina may access if Chemours fails to comply with its NC consent order.
  • The parties agreed on how these payments count toward the January 2021 Memorandum of Understanding (MOU) qualified spend cap: $210 million (the net present value of the North Carolina payments, discounted at 8% over 25 years) will be applied against the MOU’s $4 billion aggregate qualified spend cap. The same NPV method was used for the 2025 New Jersey settlement and will be used for future multi-year settlements. Because the New Jersey and North Carolina settlement payments qualify for, and exceed, required future withdrawals/contributions to the MOU Escrow Account, future escrow contribution obligations are deemed satisfied.

Key Details

  • Total settlement to North Carolina and subdivisions: $455 million paid over 15 years.
  • Corteva’s approximate direct payment share: $66 million.
  • Guarantee split for Chemours’ obligations: Corteva 29% / DuPont 71%.
  • Reserve/credit support available to the State if Chemours defaults: capped at $135 million.
  • NPV treatment: $210 million credited against the MOU $4B cap (8% discount rate over 25 years).

Why It Matters

  • Cash and contingent obligations: Corteva expects a direct payment of about $66M; it also accepts a contingent exposure by guaranteeing 29% of Chemours’ obligations and participating in a $135M capped reserve arrangement. These create both a known cash outflow and potential contingent liability if Chemours fails to perform.
  • MOU and escrow implications: Applying an NPV to these settlements reduces the remaining amount available under the MOU’s $4B qualified spend cap and effectively satisfies future escrow contribution obligations, which could reduce future cash obligations among the MOU parties.
  • For investors: this filing discloses a material legal settlement affecting environmental liabilities and intercompany obligations. The filing does not state any accounting charge or detailed financial statement impact for Corteva in this 8-K; review Corteva’s upcoming periodic filings for any recorded charges or further detail.

AI-written summary · check the filing